Pekin Hardy Strauss Inc. reduced its stake in shares of Morgan Stanley (NYSE:MS – Free Report) by 12.9% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,060 shares of the financial services provider’s stock after selling 600 shares during the period. Pekin Hardy Strauss Inc.’s holdings in Morgan Stanley were worth $395,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Wellington Management Group LLP lifted its position in Morgan Stanley by 17.2% during the fourth quarter. Wellington Management Group LLP now owns 38,451,051 shares of the financial services provider’s stock valued at $3,585,561,000 after purchasing an additional 5,631,435 shares during the period. Capital International Investors lifted its position in Morgan Stanley by 16.3% during the first quarter. Capital International Investors now owns 28,481,070 shares of the financial services provider’s stock valued at $2,681,778,000 after purchasing an additional 3,981,528 shares during the period. Fisher Asset Management LLC lifted its position in Morgan Stanley by 2.5% during the fourth quarter. Fisher Asset Management LLC now owns 20,228,334 shares of the financial services provider’s stock valued at $1,886,292,000 after purchasing an additional 495,055 shares during the period. Bank of New York Mellon Corp lifted its position in Morgan Stanley by 2.4% during the second quarter. Bank of New York Mellon Corp now owns 12,875,677 shares of the financial services provider’s stock valued at $1,251,387,000 after purchasing an additional 303,654 shares during the period. Finally, The Manufacturers Life Insurance Company lifted its position in Morgan Stanley by 12.1% during the fourth quarter. The Manufacturers Life Insurance Company now owns 9,061,378 shares of the financial services provider’s stock valued at $844,973,000 after purchasing an additional 979,250 shares during the period. 84.19% of the stock is currently owned by institutional investors and hedge funds.
Morgan Stanley Stock Down 0.2 %
Shares of NYSE MS opened at $99.88 on Wednesday. Morgan Stanley has a 12-month low of $69.42 and a 12-month high of $109.11. The stock has a market cap of $162.32 billion, a PE ratio of 18.19, a P/E/G ratio of 1.00 and a beta of 1.37. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 2.96. The company has a 50-day moving average of $100.49 and a 200 day moving average of $96.59.
Morgan Stanley Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Wednesday, July 31st were paid a dividend of $0.925 per share. This represents a $3.70 annualized dividend and a yield of 3.70%. The ex-dividend date of this dividend was Wednesday, July 31st. This is a boost from Morgan Stanley’s previous quarterly dividend of $0.85. Morgan Stanley’s dividend payout ratio is currently 67.40%.
Insider Activity at Morgan Stanley
In related news, Director Robert H. Herz sold 1,000 shares of the company’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $106.62, for a total transaction of $106,620.00. Following the completion of the sale, the director now owns 95,908 shares of the company’s stock, valued at approximately $10,225,710.96. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, insider Daniel A. Simkowitz sold 40,000 shares of the stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $106.54, for a total value of $4,261,600.00. Following the completion of the sale, the insider now owns 442,522 shares of the company’s stock, valued at approximately $47,146,293.88. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Robert H. Herz sold 1,000 shares of the stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $106.62, for a total transaction of $106,620.00. Following the completion of the sale, the director now directly owns 95,908 shares of the company’s stock, valued at approximately $10,225,710.96. The disclosure for this sale can be found here. In the last quarter, insiders sold 252,000 shares of company stock valued at $26,546,370. Corporate insiders own 0.24% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on MS shares. Evercore ISI boosted their target price on shares of Morgan Stanley from $105.00 to $115.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. UBS Group boosted their target price on shares of Morgan Stanley from $100.00 to $105.00 and gave the company a “neutral” rating in a research report on Tuesday, July 9th. BMO Capital Markets upped their price objective on shares of Morgan Stanley from $116.00 to $118.00 and gave the stock an “outperform” rating in a research report on Thursday, July 18th. Barclays upped their price objective on shares of Morgan Stanley from $116.00 to $121.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Finally, JMP Securities reiterated a “market perform” rating on shares of Morgan Stanley in a research report on Thursday, July 18th. One research analyst has rated the stock with a sell rating, fourteen have given a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $101.73.
Read Our Latest Analysis on Morgan Stanley
Morgan Stanley Profile
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Recommended Stories
- Five stocks we like better than Morgan Stanley
- About the Markup Calculator
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- What Are Trending Stocks? Trending Stocks Explained
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- Best Stocks Under $10.00
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.